期刊文献+

半剂量光动力疗法治疗后慢性中心性浆液性脉络膜视网膜病变患者脉络膜厚度变化分析 被引量:13

Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy
原文传递
导出
摘要 目的观察慢性中心性浆液性脉络膜视网膜病变(CSC)患者半剂量维替泊芬光动力疗法(PDT)治疗前、后的脉络膜厚度变化特点。方法系列病例研究。2010年10月至2011年10月在中山大学中山眼科中心就诊的30例(35只眼)CSC患者入选本研究。所有患者均接受荧光素眼底血管造影(FFA)检查、吲哚氰绿血管造影检查(ICGA)及相干光断层扫描(OCT),被确诊为慢性CSC。所有患者接受PDT治疗,并于治疗前及治疗后1、3、6个月采用频域OCT加强深度成像测定黄斑中心凹下脉络膜厚度(SFCT)及距黄斑中心凹1.5mm处上、下、鼻、颞四方位脉络膜厚度。治疗前、后各时间点脉络膜厚度的比较采用单因素重复测量方差分析,进一步两两比较采用LSD.t检验。结果30例(35只眼)慢性CSC患者中,男性26例,女性4例,男女比例为6.5:1;年龄33~66岁。所有患眼治疗前平均SFCT值为(435.54±102.91)μm,PDT治疗后1、3、6个月SFCT分别为(373.63±106.01)、(360.69±111.06)、(369.00±108.12)μm,均较治疗前明显降低(F=108.34,P〈0.01);6个月时后极部脉络膜厚度均值较3个月时有所增加,但差异无统计学意义(LSD—t检验:P〉0.05)。其他4个测量点脉络膜厚度变化趋势与SFCT一致。结论慢性CSC患者半剂量维替泊芬PDT治疗后6个月内后极部脉络膜厚度较治疗前降低。 [Abstract] Objective To observe the choroidal thickness in eyes with chronic central serous chorioretinopathy(CSC) after half-dose photodynamic therapy (PDT). Methods Case series study. Consecutive 30 patients (35 eyes) with chronic CSC admitted from October 2010 to October 2011 in Zbongshan Ophthalmic Center were recruited in this study. Optical coherence tomography (OCT) , fundus fluorescein angiography, indoeyanine green angiography (ICGA) were performed in each patient to confirm the diagnosis. ICGA-guided PDT was performed in each patient. Choroidal thickness at subfoveal and 1500 ~m superior,inferior, nasal and temporal to the fovea were measured before PDT, 1,3 and 6 months after PDT using enhanced depth imaging OCT. Data were analyzed with one-way repeated measures ANOVA and LSD-t test when pairwise comparison was needed. Results Thirty patients, aged from 33 to 66 years old, including 26 males and 4 females ( gender ratio 6. 5 : 1 ) were recruited. Subfoveal choroidal thickness (SFCT) in chronic CSC eyes was (435.54± 102.91 )μm at baseline, which decreased significantly to ( 373.63 ± 106.01 ) μm, ( 360.69 ± 111.06 ) μm and ( 369.00 ± 108.12 ) μm at 1 month, 3 months and 6 months after PDT respectively (F = 108.34 ,P 〈 0. 01 ). At 6 months after PDT, SFCT was slightly thicker than that at the 3rd month, but no statistical significance was noted( LSD-t test: P 〉 0. 05). The changing trends of choroidal thickness at the other 4 measuring points were similar to that of the SFCT. Conclusion Choroidal thickness is reduced within 6 months post-PDT in chronic CSC eyes.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2013年第6期490-494,共5页 Chinese Journal of Ophthalmology
基金 国家自然科学基金(81100685) 高等学校博士学科点专项科研基金(20110171120102)
关键词 中心性浆液性脉络膜视网膜病变 卟啉类 光化学疗法 脉络膜 体层摄影术 光学相干 Central serous chorioretinopathy Porphyrins Photochemotherapy Choroid Tomography, optical coherence
  • 相关文献

参考文献14

  • 1Wang M, Munch IC, Hasler PW, et al. Central chorioretinopathy. Acta Ophthalmol,2008,86 : 126-145.
  • 2A1-Hinai AS, A1-Abri MS. Half-fluenee photodynamic therapy to treat chronic central serous chorioretinopathy:a case series. Oman J Ophthalmo1,2011,4 :63-66.
  • 3Ruiz-Moreno JM, Lugo FL, Armada F, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmol, 2010,88:371-376.
  • 4Uetani It, Ito Y, 0iwa K, et al. Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy. Eye (Lond) ,2012,26:640-649.
  • 5Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol, 2008,146:496-500.
  • 6陶少武,申然,杨丽萍,王根生.中心性浆液性脉络膜视网膜病变激光治疗前后中心视野的对比研究[J].中国实用眼科杂志,2007,25(7):738-739. 被引量:11
  • 7Cervera E, Montero J, Torralba C, et al. Low dose photodyrtanictherapy lor chromc central serous chonoretinopathy. Arch boc Esp Oflalmo1,2008,83 : 525-526.
  • 8李加青,丁小燕,曾婧,刘冉,左雅静,陈星,唐仕波.慢性中心性浆液性脉络膜视网膜病变患者双眼脉络膜厚度频域光相干断层扫描检查分析[J].中华眼底病杂志,2012,28(4):325-328. 被引量:16
  • 9Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickaess in fellow eyes of patients with central serous chorioretinopathy. Retina, 2011,31 : 1603-1608.
  • 10Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol, 2012,90:738-743.

二级参考文献14

  • 1Torron C, Melton B, Ferrer E, et al. Central serous choroidopathy:long term study. Arch Soc Esp Oftalmol, 2000, 75 : 103-108.
  • 2Kanyange MI., De Lacy JJ. Long-term follow-up of central serous chorioretinopathy (CSCR). Bull Soc Beige Ophthalmol, 2002,284 : 39-44.
  • 3Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow up of patients with idiopathic central serous chorioretinopathy. Retina, 2002,22 : 19 24.
  • 4Dohrmann J. Lommatzsch A, Spital G, et al. Pathogenesis of central serous ehorioretinopathy : angiogr aphic and electrophysiological studies. Ophthalmologe, 2001, 98: 1069- 1073.
  • 5Ochiai J, Kato M, Tanikawa H, et al, The changes over time in areas of abnormal choroidal staining in central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi, 2002,106 : 583 589.
  • 6Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous horioretinopat hy. Retina, 2011,31 : 1603-1608.
  • 7Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectra~domain optical coherence tomography. Am J Ophthalmol, 2008,146 .. 496-500.
  • 8Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina, 1999,19:508-512.
  • 9Spaide RF, Goldbaum M, Wong DW, et al. Serous detachment of the retina. Retina, 2003,23 : 820-846.
  • 10Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina, 2009,29 : 1469-1473.

共引文献25

同被引文献111

  • 1李福全.中药治疗中心性浆液性脉络膜视网膜病变35例[J].新乡医学院学报,2004,21(5):406-407. 被引量:5
  • 2刘都红,王兵,李文兰,张莹,高宝彬,仇海燕.中心性浆液性脉络膜视网膜病变流行病学调查及相关治疗比较研究[J].临床眼科杂志,2005,13(3):228-231. 被引量:13
  • 3Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography [ J ]. Am J Ophthalmol, 2008, 146 : 496-500.
  • 4Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes [ J ]. Am J Ophthalmol, 2009, 147 : 811-815.
  • 5Rahman W, Chen FK, Yeoh J, et al. Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2011, 52: 2267- 2271.
  • 6Ikuno Y, Tano Y. Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography [ J]. Invest Ophthalmol Vis Sci, 2009, 50:3876-3880.
  • 7Ding X, Li J, Zeng J, et al. Choroidal thickness in healthy Chinese subjects [ J ]. Invest Ophthalmol Vis Sci, 2011, 52 : 9555- 9560.
  • 8Wei WB, Xu L, Jonas JB, et al. Subfoveal choriodal thickness: the Beijing Eye Study[J]. Ophthalmology, 2013, 120:175-180.
  • 9Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes [ J ]. Am J Ophthalmol, 2009, 147:811-815.
  • 10Harada T, Machida S, Fujiwara T, et al. Choroidal findings in idiopathic uveal effusion syndrome [ J ]. Clin Ophthalmol, 2011, 5:1599-1601.

引证文献13

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部